nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0673	0.0673	CbGpPWpGaD
Levonordefrin—ADRA2B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0342	0.0342	CbGpPWpGaD
Levonordefrin—ADRA2C—Monoamine GPCRs—CHRM3—nephrolithiasis	0.032	0.032	CbGpPWpGaD
Levonordefrin—ADRA2B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0288	0.0288	CbGpPWpGaD
Levonordefrin—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0287	0.0287	CbGpPWpGaD
Levonordefrin—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.028	0.028	CbGpPWpGaD
Levonordefrin—ADRA2C—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0269	0.0269	CbGpPWpGaD
Levonordefrin—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0267	0.0267	CbGpPWpGaD
Levonordefrin—ADRA2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.026	0.026	CbGpPWpGaD
Levonordefrin—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0235	0.0235	CbGpPWpGaD
Levonordefrin—ADRA2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0218	0.0218	CbGpPWpGaD
Levonordefrin—SLC6A2—NRF2 pathway—SLC2A9—nephrolithiasis	0.0193	0.0193	CbGpPWpGaD
Levonordefrin—SLC6A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0188	0.0188	CbGpPWpGaD
Levonordefrin—SLC6A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0172	0.0172	CbGpPWpGaD
Levonordefrin—SLC6A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0172	0.0172	CbGpPWpGaD
Levonordefrin—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0171	0.0171	CbGpPWpGaD
Levonordefrin—ADRA2C—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.0162	0.0162	CbGpPWpGaD
Levonordefrin—ADRA2B—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0146	0.0146	CbGpPWpGaD
Levonordefrin—ADRA2C—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0136	0.0136	CbGpPWpGaD
Levonordefrin—ADRA2A—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.0132	0.0132	CbGpPWpGaD
Levonordefrin—SLC6A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0131	0.0131	CbGpPWpGaD
Levonordefrin—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0131	0.0131	CbGpPWpGaD
Levonordefrin—ADRA2C—Integration of energy metabolism—CHRM3—nephrolithiasis	0.0128	0.0128	CbGpPWpGaD
Levonordefrin—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0121	0.0121	CbGpPWpGaD
Levonordefrin—SLC6A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0121	0.0121	CbGpPWpGaD
Levonordefrin—ADRA2A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0111	0.0111	CbGpPWpGaD
Levonordefrin—SLC6A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0108	0.0108	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0107	0.0107	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0107	0.0107	CbGpPWpGaD
Levonordefrin—ADRA2A—Integration of energy metabolism—CHRM3—nephrolithiasis	0.0104	0.0104	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.0103	0.0103	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00966	0.00966	CbGpPWpGaD
Levonordefrin—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00966	0.00966	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00958	0.00958	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00876	0.00876	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00876	0.00876	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00864	0.00864	CbGpPWpGaD
Levonordefrin—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00837	0.00837	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00785	0.00785	CbGpPWpGaD
Levonordefrin—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00698	0.00698	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00664	0.00664	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00664	0.00664	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00661	0.00661	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00624	0.00624	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00617	0.00617	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00617	0.00617	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00617	0.00617	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00566	0.00566	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.0055	0.0055	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.0055	0.0055	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0054	0.0054	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—DGKH—nephrolithiasis	0.00533	0.00533	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—SLC7A9—nephrolithiasis	0.00533	0.00533	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00529	0.00529	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00501	0.00501	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00499	0.00499	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—SLC7A9—nephrolithiasis	0.00498	0.00498	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—DGKH—nephrolithiasis	0.00498	0.00498	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.00466	0.00466	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00462	0.00462	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—RGS14—nephrolithiasis	0.00453	0.00453	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0044	0.0044	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00431	0.00431	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0043	0.0043	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—RGS14—nephrolithiasis	0.00423	0.00423	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00407	0.00407	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.00405	0.00405	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.00405	0.00405	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.00403	0.00403	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—PTH—nephrolithiasis	0.00394	0.00394	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00379	0.00379	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.0037	0.0037	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—PTH—nephrolithiasis	0.00368	0.00368	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00352	0.00352	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.00344	0.00344	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.00337	0.00337	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00327	0.00327	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00322	0.00322	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.00315	0.00315	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADCY10—nephrolithiasis	0.00315	0.00315	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—DGKH—nephrolithiasis	0.00306	0.00306	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.00299	0.00299	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GRHPR—nephrolithiasis	0.00299	0.00299	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ADCY10—nephrolithiasis	0.00294	0.00294	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—DGKH—nephrolithiasis	0.00286	0.00286	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00275	0.00275	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—RGS14—nephrolithiasis	0.00268	0.00268	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—AGXT—nephrolithiasis	0.00266	0.00266	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00257	0.00257	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00256	0.00256	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RGS14—nephrolithiasis	0.0025	0.0025	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.0025	0.0025	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00244	0.00244	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.00243	0.00243	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.00239	0.00239	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.00232	0.00232	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00228	0.00228	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—APRT—nephrolithiasis	0.00227	0.00227	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—SLC26A1—nephrolithiasis	0.00227	0.00227	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	0.00223	0.00223	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.00221	0.00221	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.00219	0.00219	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.00216	0.00216	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—PTH—nephrolithiasis	0.00208	0.00208	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.00207	0.00207	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.00203	0.00203	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	0.00202	0.00202	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00199	0.00199	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PTH—nephrolithiasis	0.00189	0.00189	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00185	0.00185	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.00184	0.00184	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—APRT—nephrolithiasis	0.00184	0.00184	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.00182	0.00182	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00181	0.00181	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	0.00181	0.00181	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00181	0.00181	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.00169	0.00169	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—DGKH—nephrolithiasis	0.00169	0.00169	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00169	0.00169	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00168	0.00168	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.00165	0.00165	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—AQP1—nephrolithiasis	0.00161	0.00161	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.00154	0.00154	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00148	0.00148	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.00148	0.00148	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CHRM3—nephrolithiasis	0.00146	0.00146	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00137	0.00137	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.00137	0.00137	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.00131	0.00131	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	0.00131	0.00131	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CHRM3—nephrolithiasis	0.00122	0.00122	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	0.0012	0.0012	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.00119	0.00119	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PTH—nephrolithiasis	0.00112	0.00112	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.00107	0.00107	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000992	0.000992	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000976	0.000976	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000907	0.000907	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	0.0006	0.0006	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SPP1—nephrolithiasis	0.000561	0.000561	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.00049	0.00049	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	0.000455	0.000455	CbGpPWpGaD
